EFNS guidelines on neuropathic pain assessment

European Journal of Neurology

Volumn 11, Issue 3, 2004, Pages 153-162

  Cruccu, G ^a,b,j   Anand, P ^c   Attal, N ^d   Garcia Larrea, L ^a,e   Haanpaa M ^a,f   Jorum E ^a,g   Serra, J ^a,h   Jensen, T S ^a,i  

^a EFNS Panel on Neuropathic Pain   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e UNIVERSITÉ LYON 1   (France)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h HOSPITAL GENERAL DE CATALUNYA   (Spain)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

^j SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

Laser evoked potentials; Neuroimaging; Neuropathic pain; Nociceptive reflexes; Psychometric measures; Quality of life; Skin biopsy

Indexed keywords

CENTRAL NERVOUS SYSTEM; COGNITION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ELECTRODIAGNOSIS; EVOKED RESPONSE; EVOKED SOMATOSENSORY RESPONSE; LASER; LASER EVOKED POTENTIAL; MEDICAL SOCIETY; NERVE BIOPSY; NERVE CONDUCTION; NERVE LESION; NEUROGRAPHY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; NOCICEPTION; NOCICEPTIVE REFLEX; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PAIN; PAIN ASSESSMENT; PERIPHERAL NERVE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; REFLEX; REVIEW; SENSORY EVALUATION; SKIN BIOPSY;

EUROPE; EVOKED POTENTIALS, SOMATOSENSORY; HUMANS; NEUROLOGIC EXAMINATION; PAIN; PAIN MEASUREMENT; SOCIETIES, MEDICAL;

EID: 1642351119     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2004.00791.x     Document Type: Review

References (102)

1. Agostino R, Cruccu G, Romaniello A, Innocenti P, Inghilleri M, Manfredi M (2000). Dysfunction of small myelinated afferents in diabetic polyneuropathy, as assessed by laser evoked potentials. Clin Neurophysiol 111:270-276.
2. American Diabetes Association and American Academy of Neurology (1988). Consensus Statement. Report and recommendations of the San Antonio Conference on diabetic neuropathy. Diabetes 37:1000-1004.
3. Attal N, Gaude V, Dupuy M (2000). Intravenous lidocaine in central pain. A double-blind placebo-controlled psychophysical study. Neurology 544:564-574.
4. Attal N, Guirimand F, Brasseur L, Gaude V, Chauvin M, Bouhassira D (2002). Effects of IV morphine in central pain: a randomized placebo-controlled study. Neurology 58:554-563.
5. Baranowski AP, De Courcey J, Bonello E (1999). A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 17:429-434.
6. Baron R, Baron Y, Disbrow E, Roberts TP (1999). Brain processing of capsaicin-induced secondary hyperalgesia: a functional MRI study. Neurology 53:548-557.
7. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J (1961). An inventory to measure depression. Arch Gen Psychiatry 4:561-567.
8. Belfrage M, Sollevi A, Segerdahl M, Sjolund KF, Hansson P (1995). Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg 81:713-717.
9. Bennett M (2001). The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 92:147-157.
10. Boureau F, Luu M, Doubrere JF (1991). Study of experimental pain measures and nociceptive reflex in chronic pain patients and normal subjects. Pain 44:131-138.
11. Bragard D, Chen AC, Plaghki L (1996). Direct isolation of ultra-late (C-fibre) evoked brain potentials by CO2 laser stimulation of tiny cutaneous surface areas in man. Neurosci Lett 209:81-84.
12. Bromm B, Treede RD (1984). Nerve fibre discharges, cerebral potentials and sensations induced by CO2 laser stimulation. Hum Neurobiol 3:33-40.
13. Bromm B, Treede RD (1987). Human cerebral potentials evoked by CO2 laser stimuli causing pain. Exp Brain Res 67:153-162.
14. Bromm B, Treede RD (1991). Laser-evoked cerebral potentials in the assessment of cutaneous pain sensitivity in normal subjects and patients. Rev Neurol (Paris) 147:625-643.
15. Campero M, Serra J, Ochoa JL (1996). C-polymodal nociceptors activated by noxious low temperature in human skin. J Physiol 497:565-572.
16. Campero M, Serra J, Marchettini P, Ochoa JL (1998). Ectopic impulse generation and autoexcitation in single myelinated afferent fibers in patients with peripheral neuropathy and positive sensory symptoms. Muscle Nerve 21:1661-1667.
17. Casey KL, Beydoun A, Boivie J et al. (1996). Laser-evoked cerebral potentials and sensory function in patients with central pain. Pain 64:485-491.
18. Chan AW, McFarlane IA, Bowsher D, Campbell JA (1992). Weighted needle pinprick sensory thresholds: a simple test of sensory function in diabetic peripheral neuropathy. J Neurol Neurosurg Psychiatry 55:56-59.
19. Claus D, Hilz MJ, Hummer I, Neundörfer B (1987). Methods of measurement of thermal thresholds. Acta Neurol Scand 76:288-296.
20. Cruccu G, Leandri M, Feliciani M, Manfredi M (1990). Idiopathic and symptomatic trigeminal pain. J Neurol Neurosurg Psychiatry 53:1034-1042.
21. Cruccu G, Ferracuti S, Leardi MG, Fabbri A, Manfredi M (1991). Nociceptive quality of the orbicularis oculi reflexes as evaluated by distinct opiate- and benzodiazepine-induced changes in man. Brain Res 556:209-217.
22. Cruccu G, Leandri M, Iannetti GD et al. (2001). Small-fiber dysfunction in trigeminal neuralgia: carbamazepine effect on laser-evoked potentials. Neurology 56:1722-1726.
23. Devers A, Galer BS (2000). Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain 16:205-208.
24. Eide PK, Jorum E, Stubhaub A, Bremmes J, Breivik H (1994). Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 58:347-354.
25. Eide PK, Stubhaug A, Stenehjem AE (1995). Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery 37:1080-1087.
26. Farrar JT, Young JP Jr, LaMoreaux L, Weth JL, Poole MR (2001). Clinical importance of change in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149-158.
27. Felsby S, Nielsen J, Arendt Nielsen L, Jensen TS (1996). NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 64:283-291.
28. Ferrans C (1990). Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17(Suppl. 3): 15-19.
29. Follick MJ, Smith TW, Ahern DK (1985). The sickness impact profile: a global measure of disability in chronic low back pain. Pain 21:67-76.
30. Fruhstorfer H, Lindblom U, Schmidt WG (1976). Method for quantitative estimation of thermal threshold in patients. J Neurol Neurosurg Psychiatry 39:1071-1075.
31. Galer BS, Jensen MP (1997). Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 48:332-338.
32. Garcia-Larrea L, Sindou M, Mauguiere F (1989). Nociceptive flexion reflexes during analgesic neurostimulation in man. Pain 39:145-156.
33. Garcia-Larrea L, Peyron R, Mertens P et al. (1999). Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study. Pain 83:259-273.
34. Garcia-Larrea L, Convers P, Magnin M et al. (2002). Laser-evoked potential abnormalities in central pain patients: the influence of spontaneous and provoked pain. Brain 125:2766-2781.
35. Goldberg JM, Lindblom U (1979). Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatry 42:793-803.
36. Gracely RH, McGrath F, Dubner R (1978). Ratio scales of sensory and affective verbal pain descriptors. Pain 5:5-18.
37. Granot M, Buskila D, Granovsky Y, Sprecher E, Neumann L, Yarnitsky D (2001). Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia. Clin Neurophysiol 112:1881-1887.
38. Hansson P (1994). Possibilities and potential pitfalls of combined bedside and quantitative somatosensory analysis in pain patients. In: Boivie J, Hansson P, Lindblom U, eds. Progress in Pain Research and Management, Vol. 3, Touch, temperature and pain in health and disease. IASP Press, Seattle, WA, pp. 113-132.
39. Hansson PT, Fields HL, Hill RG, Marchettini P (2001). Progress in Pain Research and Management, Vol. 21, Neuropathic pain: pathophysiology and treatment. IASP Press, Seattle, WA.
40. Hermann DN, Griffin JW, Hauer BS, Cornblath DR, McArthur JC (1999). Epidermal nerve fibre density and sural nerve morphometry in peripheral neuropathies. Neurology 53:1634-1640.
41. Holland NR, Stocks A, Hauer P, Cornblath DR, Griffin JW, McArthur JC (1997). Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology 48:708-711.
42. Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC (1998). Small fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 44:47-59.
43. Hsieh JC, Belfrage M, Stone-Elander S, Hansson P, Ingvar M (1995). Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 63:225-236.
44. Hughes RA, Barnes MP, Baron JC, Brainin M (2001). European Federation of Neurological Societies. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces. Eur J Neurol 8:549-550.
45. Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E (1980). A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 34:281-286.
46. Huskisson EC (1974). Measurement of pain. Lancet 2:1127-1131.
47. Iadarola MJ, Max MB, Berman KF et al. (1995). Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain 63:55-64.
48. Inghilleri M, Conte A, Frasca V et al. (2002). Is the cutaneous silent period an opiate-sensitive nociceptive reflex? Muscle Nerve 25:695-699.
49. Jensen TS, Gottrup H, Bach FW, Sindrup SH (2001). The clinical picture of neuropathic pain. Eur J Pharmacol 429:1-11.
50. Kakigi R, Shibasaki H, Kuroda Y et al. (1991). Pain-related somatosensory evoked potentials in syringomyelia. Brain 114:1871-1889.
51. Kakigi R, Shibasaki H, Ikeda T, Neshige R, Endo C, Kuroda Y (1992). Pain-related somatosensory evoked potentials following CO2 laser stimulation in peripheral neuropathies. Acta Neurol Scand 85:347-352.
52. Krause SJ, Backonja MM (2003). Development of a neuropathic pain questionnaire. Clin J Pain 19:306-314.
53. Kvinesdal B, Molin J, Froland A, Gram LF (1984). Imipramine treatment of painful diabetic neuropathy. JAMA 251:1727-1730.
54. Lankers J, Frieling A, Kunze K, Bromm B (1991). Ultralate cerebral potentials in a patient with hereditary motor and sensory neuropathy type I indicate preserved C-fibre function. J Neurol Neurosurg Psychiatry 54:650-652.
55. Leffler AS, Kosek E, Hansson P (2000). The influence of pain intensity on somatosensory perception in patients suffering from subacute/chronic lateral epicondylalgia. Eur J Pain 4:57-71.
56. Leffler AS, Kosek E, Lerndal T, Nordmark B, Hansson P (2002). Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. Eur J Pain 6:161-176.
57. Leung A, Wallace MS, Ridgeway B, Yaksh T (2001). Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain 91:177-187.
58. Llewelyn JG, Gilbey SG, Thomas PK, King RHM, Muddle JR, Watkins PJ (1991). Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy: a clinicopathological study. Brain 114:867-892.
59. Lorenz J, Beck H, Bromm B (1997). Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain 73:369-375.
60. McCarthy BG, Hsieh ST, Stocks A et al. (1995). Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 45:1848-1855.
61. McCracken LM, Zayfert C, Gross T (1992). The Pain Anxiety Symptoms Scale: development and validation of a scale to measure fear of pain. Pain 50:67-73.
62. McQuay H, Moore A (1998). An Evidence-Based Resource for Pain Relief. Oxford University Press, Oxford.
63. Magerl W, Ali Z, Ellrich J, Meyer RA, Treede RD (1999). C- and A delta-fiber components of heat-evoked cerebral potentials in healthy human subjects. Pain 82:127-137.
64. Marchettini P, Lacerenza M, Marangoni C, Pellegata G, Sotgiu ML, Smirne S (1992). Lidocaine test in neuralgia. Pain 48:377-382.
65. Melzack R (1975). The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:275-299.
66. Melzack R (1987). The short-form McGill Pain Questionnaire. Pain 30:191-197.
67. Merskey H, Bogduk N (1994). Task Force on Taxonomy of the International Association for the Study of Pain: Classification of Chronic Pain. Description of Pain Syndromes and Definitions of Pain Terms. IASP Press, Seattle, WA.
68. Meyer-Rosberg K, Kvarnström A, Kinnman E, Gordh T, Nordfors L, Kristofferson A (2001a). Peripheral neuropathic pain - multidimensional burden for patients. Eur J Pain 5:379-389.
69. Meyer-Rosberg K, Bruckhardt CS, Huizar K, Kvarnström A, Nordfors L, Kristofferson A (2001b). A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain. Eur J Pain 5:391-403.
70. Nolano M, Provitera V, Crisci C et al. (2003). Quantification of myelinated endings and mechanoreceptors in human digital skin. Ann Neurol 54:197-205.
71. Peripheral Neuropathy Association (1993). Quantitative sensory testing: a consensus report from the peripheral neuropathy association. Neurology 43:1050-1052.
72. Periquet MI, Novak V, Collins MP et al. (1999). Painful sensory neuropathy - prospective evaluation using skin biopsy. Neurology 53:1641-1647.
73. Peyron R, Laurent B, Garcia-Larrea L (2000). Functional imaging of brain responses to pain. A review and meta-analysis. Neurophysiol Clin 30:263-288.
74. Pud D, Eisenberg E, Spitzer A, Adler R, Fried G, Yarnitsky D (1998). The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double-blind randomized, placebo controlled trial. Pain 75:349-354.
75. Rowbotham MC, Davies PS, Fields HL (1995). Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 37:246-253.
76. Rowbotham MC, Davies PS, Verkempinck C, Galer BS (1996). Lidocaine patch: double-blind controlled study of a new treatment method for postherpetic neuralgia. Pain 65:38-44.
77. Sandrini G, Milanov I, Malaguti S, Nigrelli MP, Moglia A, Nappi G (2000). Effects of hypnosis on diffuse noxious inhibitory controls. Physiol Behav 69:295-300.
78. Sandrini G, Tassorelli C, Cecchini AP, Alfonsi E, Nappi G (2002). Effects of nimesulide on nitric oxide-induced hyperalgesia in humans - a neurophysiological study. Eur J Pharmacol 450:259-262.
79. Serrao M, Parisi L, Pierelli F, Rossi P (2001). Cutaneous afferents mediating the cutaneous silent period in the upper limbs: evidence for a role of low-threshold sensory fibres. Clin Neurophysiol 112:2007-2014.
80. Sindrup SH, Jensen TS (1999). Effects of pharmacological treatment of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83:389-400.
81. Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TJ (1999). Tramadol relieves pain and allodynia in polyneuropathy: a randomised double blind controlled trial. Pain 83:85-90.
82. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS (2003). Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 60:1284-1289.
83. Sjolund KF, Belfrage M, Karlsten R et al. (2001). Systemic adenosine infusion reduces the area of tactile allodynia in neuropathic pain following peripheral nerve injury: a multicentre, placebo-controlled study. Eur J Pain 5:199-207.
84. Smith WB, Gracely RH, Safer MA (1998). The meaning of pain: cancer patient's rating and recall of pain intensity and affect. Pain 78:123-129.
85. Spielberg CD (1975). The measurement of state and trait anxiety; conceptual and methodological issues. In: Levi L, ed. Emotions: their Parameters and Measurement. Raven Press, New York, pp. 713-725.
86. Torebjork E (1993). Human microneurography and intraneural microstimulation in the study of neuropathic pain. Muscle Nerve 16:1063-1065.
87. Treede R-D, Meyer RA, Raja SN, Campbell JN (1995). Evidence for two different heat transduction mechanisms in nociceptive primary afferents innervating monkey skin. J Physiol 483:747-758.
88. Truini A, Haanpaa M, Zucchi R et al. (2003). Laser-evoked potentials in post-herpetic neuralgia. Clin Neurophysiol 114:702-709.
89. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS (2001). Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 56:184-190.
90. Wallace MS, Magnuson S, Ridgeway B (2000). Efficacy of oral mexiletine for neuropathic pain with allodynia: a double blind placebo controlled cross over study. Reg Anesth Pain Med 25:459-467.
91. Wallace MS, Rowbotham MC, Katz NP et al. (2002). A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology 59:1694-1700.
92. Ware JE Jr, Sherbourne CD (1992). The MOS 36-item Short-Form Health Survey. Med Care 30:473-483.
93. Watson CPN, Chipman M, Reed K, Evans RJ, Birkett N (1992). Amitriptyline versus maprotiline in postherpetic neuralgia: a randomised, double blind, cross over study. Pain 48:29-36.
94. Waylett-Rendall J (1988). Sensibility evaluation and rehabilitation. Orthop Clin North Am 19:43-56.
95. Wendler J, Hummel T, Reissinger M et al. (2001). Patients with rheumatoid arthritis adapt differently to repetitive painful stimuli compared to healthy controls. J Clin Neurosci 8:272-277.
96. Willer JC (1985). Studies on pain. Effects of morphine on a spinal nociceptive flexion reflex and related pain sensation in man. Brain Res 331:105-114.
97. Willer JC, Roby A, Le Bars D (1984). Psychophysical and electrophysiological approaches to the pain-relieving effects of heterotopic nociceptive stimuli. Brain 107:1095-1112.
98. Willer JC, De Broucker T, Bussel B, Roby-Brami A, Harrewyn JM (1989). Central analgesic effect of ketoprofen in humans: electrophysiological evidence for a supraspinal mechanism in a double-blind and cross-over study. Pain 38:1-7.
99. Woolf CJ, Max M (2001). Mechanism based pain diagnosis. Anesthesiology 95:241-249.
100. Yarnitsky D, Sprecher E, Zaslansky R, Hemli JA (1995). Heat pain thresholds: normative data and repeatability. Pain 60:329-332.
101. Zigmond AS, Snaith RP (1983). The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370.
102. Zung WWK (1965). A self-rating depression scale. Arch Gen Psychiatry 12:63-70.